Wekerle, Hartmut

11 August 2018
1616 Views
MaxPlanck Institute of Neurobiology

Emeritus Research Group – Neuroimmunology
Hertie Senior Professorship
Martinsried

Hartmut Wekerle was director and member of the Max Planck Institute of Neurobiology. In 2012 he was awarded a Hertie Senior Professorship, and he leads an Extended Emeritus Group. Hartmut Wekerle’s scientific research focuses on the mechanisms initiating and driving multiple sclerosis and its experimental models, which imply autoimmune attack against the nervous system. Wekerle’s work led to the identification of brain reactive autoimmune T lymphocytes in the immune system.

Most recently, he identified the commensal bacterial gut flora as a factor triggering the pathogenic potential of immune cells. He develops and uses new imaging approaches to detail the mechanisms of autoimmune T cell migration into the brain. Wekerle has received numerous awards, including the Jung Prize, Zülch Prize, Koetser Prize, Charcot Award (MS International Federation), Grand Prix Louis D. (Institut de France), and a Koselleck Award (DFG).
He holds an Honorary Professorship of the University of Munich and Honorary Doctorates of the Universities of Hamburg and Würzburg. He is a member of the German Academy of Science (Leopoldina), Honorary Member of the Société Française de Neurologie and Honorary Member of the Cuban Neuroscience Society.

You may be interested

Senza categoria
48 views

ISNI Events

stine - 25 February 2021

[em_events view="x" types="1,2,…" sites="1,2,…" show="5"]

Charité Universitätsmedizin Berlin – Junior Professorship for Applied Visual Systems Research (Endowed Professorship)
Job Opportunities
169 views
Job Opportunities
169 views

Charité Universitätsmedizin Berlin – Junior Professorship for Applied Visual Systems Research (Endowed Professorship)

stine - 25 February 2021

Junior Professorship for Applied Visual Systems Research (Endowed Professorship) Salary Group W1 BBesG-ÜfBE – non-tenured (3 years) (Kennziffer: Prof.569/2020)  The…

Joint session EAN/ISNI Immune checkpoint inhibitors: a step towards precision neurology
News
306 views
News
306 views

Joint session EAN/ISNI Immune checkpoint inhibitors: a step towards precision neurology

stine - 25 January 2021

FW12 Sunday, June 20 2021 08:00 a.m. - 09:30 a.m. Organized by Roland Liblau and Alberto Vogrig